Pfizer Inc.

We’re celebrating over 175 years of daring scientific innovation and we’re not done yet. Protect your health at

[Pfizer Inc. @pfizer]

When prostate cancer becomes resistant to traditional hormone therapies, new treatment approaches are needed.

Pfizer researchers are studying EZH2 and exploring ways to potentially reprogram treatment resistance in metastatic prostate cancer.

Learn more: https://t.co/35IqXhhy3H

[Pfizer Inc. @pfizer]

💊 Most people never question whether the medicine in their cabinet is real, but the illicit worldwide counterfeit drugs network is vast, adaptive, and relentless.

Here's how we’re helping combat counterfeits, disrupt criminal networks, and protect patients: https://t.co/giN5XWPdss

[Pfizer Inc. @pfizer]

What is one challenge in ATTR-CM you would like to highlight?

At #ESCCongress in Munich, leading clinicians in the field told us what they thought.

At Pfizer, we are committed to advancing understanding and awareness of ATTR-CM to improve outcomes for patients.

[Pfizer Inc. @pfizer]

As #ESCCongress 2026 returns to Munich, early diagnosis and treatment initiation remain the biggest opportunity to improve outcomes in ATTR-CM, an underdiagnosed cause of heart failure.

Explore how the landscape has evolved and what needs to happen next: https://t.co/pzodOzmLkN

[Pfizer Inc. @pfizer]

250 years of American innovation have shown what’s possible when different minds and ideas come together.

As we look to what’s next, Pfizer is proud to build on that spirit of innovation, continuing to advance science and explore what’s possible for the future of medicine.

#America250

[Pfizer Inc. @pfizer]

Every dose of medicine you take is the final step in a long journey—one that runs through qualified suppliers, rigorous testing, and continuous monitoring.

Pfizer's Bina Nair and Kenya Edmondson walk through what it takes to make sure every dose performs the same way, everywhere: https://t.co/jtyvMBN51X

#PharmaManufacturing #QualityAssurance

[Pfizer Inc. @pfizer]

For more than a century, scientists studied cancer as a caricature of healthy tissue. Spatial transcriptomics is changing that. Now, with the ability to map tumors cell by cell, researchers are rethinking what’s possible in cancer treatment.

Read more: https://t.co/13ies7udcU

#Oncology #CancerResearch #PrecisionMedicine

[Pfizer Inc. @pfizer]

Our global survey found unspoken compromises may persist in hemophilia care, pointing to a need for more open conversations. With 6 in 10 patients saying HCPs are their primary source of information on newer treatments, shared-decision making can help evolve care. See more: https://t.co/2ygb4aXGor

[Pfizer Inc. @pfizer]

Most scientific discoveries begin in a lab. Reaching patients requires something else entirely: a global system built to produce medicines consistently, at scale, without ever compromising on quality.

Read more: https://t.co/zE603gyNY0

#GlobalHealth #PatientAccess

[Albert Bourla @AlbertBourla]

Our second quarter results are out today, and I am proud to report another strong quarter of execution. Thank you to my @pfizer colleagues, all of you, for everything behind these results and for your commitment to our purpose: breakthroughs that change patients’ lives.

[Pfizer Inc. @pfizer]

Not all migraine attacks are random. Hormonal shifts across the menstrual cycle can trigger longer, more severe attacks. Here’s what the research reveals about menstrual migraine: https://t.co/JHkekCuZz9

#MigraineAwareness #HormoneHealth #WomensHealth

[Pfizer Inc. @pfizer]

“My daughter is my driving force. She’s what I’m truly living for.”

After a rare cancer diagnosis, Isis Kanevsky shares the lessons that ground her as she navigates treatment and survivorship. https://t.co/HGMSQBzVDy

#CancerSurvivorship #CancerAwareness #RareDisease

[Pfizer Inc. @pfizer]

GLP-1. GIP. Amylin. NuSH.

What sounds like “alphabet soup” is actually reshaping how researchers understand obesity.

New science is revealing how hormones, brain signaling, metabolism, and the gut-brain axis influence weight regulation — and is driving updated approaches to treatment.

Read more: https://t.co/7qpUhdhIvF

#GLP1 #ObesityScience #Metabolism #Healthcare

[Pfizer Inc. @pfizer]

For years, Dan Morgan has helped doctors understand the role certain medications can play in cancer care. At age 46, he became a patient.

Because he was proactive about prostate cancer screening, doctors caught it early. Now, Dan’s sharing his story.

https://t.co/I15Gkoz3tP

[Pfizer Inc. @pfizer]

The first participants have been dosed in VESPER-6 and SOLIS-1, part of 20+ study starts planned across Pfizer's obesity pipeline in 2026.

Learn more about our pipeline: https://t.co/jwSrtL2a3j

[Albert Bourla @AlbertBourla]

We dosed the first participants in VESPER-6, the latest Phase 3 trial of our lead investigational medicine in obesity and started a Phase 2b study testing it in combination with an investigational amylin analog.

[Pfizer Inc. @pfizer]

Vaccine development is complex, but experience makes the difference.

At Pfizer, decades of vaccine innovation are helping our scientists explore new ways to help prevent disease caused by C. difficile infection. Learn more: https://t.co/7vp0Om5Cp1

[Pfizer Inc. @pfizer]

Pfizer is at #EHA2026 in Stockholm this week presenting 20+ abstracts across blood cancers, sickle cell disease, and hemophilia — committed to turning breakthroughs into real-world impact for patients and those who love them.

[Pfizer Inc. @pfizer]

Pfizer is advancing obesity science. New Phase 2b data for our investigational GLP‑1 RA peptide show robust efficacy and favourable GI tolerability across weekly and monthly dosing, supporting our extensive pivotal program.

Learn more: [link]

#ADASciSessions #Obesity #GLP1 #ClinicalTrials #Innovation #Healthcare

[Pfizer Inc. @pfizer]

Not all migraine attacks are random. Hormonal shifts during your menstrual cycle can trigger longer attacks with more severe symptoms.

Understanding the science can help you anticipate triggers and explore ways to address symptoms. https://t.co/952OwLpjvy

#MigraineRelief #HormoneHealth#WomensHealth

[Pfizer Inc. @pfizer]

At #ADASciSessions this weekend, new Phase 2b data from our obesity pipeline will feature at a late-breaking expert symposium. At Pfizer we’re working to advance treatment approaches intended to address the many needs of people living with obesity and related comorbidities. Learn more about this important area of research: https://t.co/HHBAii5TbE

#Obesity #ClinicalTrials #Innovation #Healthcare